Veness Adam M
SEC insider (Form 3/4/5 filer). CIK 0001778623. SVP, General Counsel and Sec. at Dianthus Therapeutics, Inc. /DE/ (DNTH). 11 reported Form 4/5 transactions since Sep 2024; latest on Aug 13, 2026. Located in NEW YORK, NY.
Companies Veness Adam M has filed insider reports for
- Dianthus Therapeutics, Inc. /DE/ (DNTH): Officer, SVP, General Counsel and Sec.
Veness Adam M
CIK: 0001778623
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Dianthus Therapeutics, Inc. /DE/
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Aug 13, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
ExerciseDirect15K shares at avg. $18.17$273K - Aug 10, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
ExerciseDirect16.2K shares at avg. $17.88$289K - Aug 10, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
SaleDirect16.2K shares at avg. $110.38$1.8M - Aug 7, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
SaleDirect3.2K shares at avg. $110.61$356K - Aug 7, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
SaleDirect616 shares at avg. $111.18$68K - Aug 7, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
ExerciseDirect3.8K shares at avg. $17.88$69K - Jun 17, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
ExerciseDirect30K shares at avg. $17.88$536K - Jun 17, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
SaleDirect16.8K shares at avg. $80.34$1.3M - Jun 17, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
SaleDirect13.2K shares at avg. $81.38$1.1M - Feb 3, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
AwardDirectStock Option (Right to Buy)
100K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 13, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Exercise | 15,000 | $18.17 | $272,550 | Direct |
| Aug 10, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Exercise | 16,167 | $17.88 | $289,066 | Direct |
| Aug 10, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Sale | 16,167 | $110.38 | $1,784,513 | Direct |
| Aug 7, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Sale | 3,217 | $110.61 | $355,832 | Direct |
| Aug 7, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Sale | 616 | $111.18 | $68,487 | Direct |
| Aug 7, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Exercise | 3,833 | $17.88 | $68,534 | Direct |
| Jun 17, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Exercise | 30,000 | $17.88 | $536,400 | Direct |
| Jun 17, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Sale | 16,771 | $80.34 | $1,347,382 | Direct |
| Jun 17, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Sale | 13,229 | $81.38 | $1,076,576 | Direct |
| Feb 3, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Award Stock Option (Right to Buy) | 100,000 | - | - | Direct |
1-10 of 11 transactions